Telomere dysfunction and tumour suppression: the senescence connection (original) (raw)

• Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621 (1961). A classic paper demonstrating that human cells have finite proliferative capacity in vitro (the 'Hayflick limit').
  CAS PubMed Google Scholar
• Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995). This paper reports on the SA-β-gal assay as a way to mark senescent cells.
  CAS PubMed PubMed Central Google Scholar
• Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998).
  CAS PubMed Google Scholar
• Vaziri, H. & Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279–282 (1998).
  CAS PubMed Google Scholar
• Maser, R. S. & DePinho, R. A. Connecting chromosomes, crisis, and cancer. Science 297, 565–569 (2002).
  CAS PubMed Google Scholar
• Masutomi, K. et al. Telomerase maintains telomere structure in normal human cells. Cell 114, 241–253 (2003).
  CAS PubMed Google Scholar
• Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W. & Shay, J. W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18, 173–179 (1996).
  CAS PubMed Google Scholar
• Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458–460 (1990). This report links increasing telomere attrition with increased cell divisions and advancing age, suggesting that telomere shortening may be the underlying mechanism of the Hayflick limit.
  CAS PubMed Google Scholar
• Allsopp, R. C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA 89, 10114–10118 (1992).
  CAS PubMed PubMed Central Google Scholar
• Harley, C. B. et al. Telomerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol. 59, 307–315 (1994).
  CAS PubMed Google Scholar
• Blasco, M. A. Telomere length, stem cells and aging. Nature Chem. Biol. 3, 640–649 (2007).
  CAS Google Scholar
• Griffith, J. D. et al. Mammalian telomeres end in a large duplex loop. Cell 97, 503–514 (1999).
  CAS PubMed Google Scholar
• de Lange, T. T-loops and the origin of telomeres. Nature Rev. Mol. Cell Biol. 5, 323–329 (2004).
  CAS Google Scholar
• McClintock, B. the stability of broken ends of chromosomes in Zea Mays. Genetics 26, 234–282 (1941).
  CAS PubMed PubMed Central Google Scholar
• de Lange, T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100–2110 (2005).
  CAS PubMed Google Scholar
• Liu, D., O'Connor, M. S., Qin, J. & Songyang, Z. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J. Biol. Chem. 279, 51338–51342 (2004).
  CAS PubMed Google Scholar
• Verdun, R. E. & Karlseder, J. Replication and protection of telomeres. Nature 447, 924–931 (2007).
  CAS PubMed Google Scholar
• Corneo, B. et al. Rag mutations reveal robust alternative end joining. Nature 449, 483–486 (2007).
  CAS PubMed Google Scholar
• Yan, C. T. et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 449, 478–482 (2007).
  CAS PubMed Google Scholar
• Capper, R. et al. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 21, 2495–2508 (2007).
  CAS PubMed PubMed Central Google Scholar
• DePinho, R. A. & Polyak, K. Cancer chromosomes in crisis. Nature Genet. 36, 932–934 (2004).
  CAS PubMed Google Scholar
• d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198 (2003).
  CAS PubMed Google Scholar
• Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549–1556 (2003). References 22 and 23 report that dysfunctional telomeres activate a DDR, resulting in the accumulation of DDR proteins at telomeres. Cells with dysfunctional telomeres enter into senescence by activating a p53-dependent checkpoint response.
  CAS PubMed Google Scholar
• Wright, W. E. & Shay, J. W. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27, 383–389 (1992). This paper documents that DNA damage checkpoint proteins such as p53 and RB are required for cells with shortened telomeres to undergo cellular senescence. Elimination of these proteins enables these cells to immortalize.
  CAS PubMed Google Scholar
• Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19_ARF_. Cell 91, 649–659 (1997).
  CAS PubMed Google Scholar
• Sage, J., Miller, A. L., Perez-Mancera, P. A., Wysocki, J. M. & Jacks, T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223–228 (2003).
  CAS PubMed Google Scholar
• Guo, X. et al. Dysfunctional telomeres activate an ATM–ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J. 26, 4709–4719 (2007).
  CAS PubMed PubMed Central Google Scholar
• Churikov, D. & Price, C. M. Pot1 and cell cycle progression cooperate in telomere length regulation. Nature Struct. Mol. Biol. 15, 79–84 (2008).
  CAS Google Scholar
• Gire, V., Roux, P., Wynford-Thomas, D., Brondello, J. M. & Dulic, V. DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J. 23, 2554–2563 (2004).
  CAS PubMed PubMed Central Google Scholar
• Denchi, E. L. & de Lange, T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448, 1068–1071 (2007).
  CAS PubMed Google Scholar
• Lee, H. W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998).
  CAS PubMed Google Scholar
• Rudolph, K. L. et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701–712 (1999).
  CAS PubMed Google Scholar
• Rajaraman, S. et al. Telomere uncapping in progenitor cells with critical telomere shortening is coupled to S-phase progression in vivo. Proc. Natl Acad. Sci. USA 104, 17747–17752 (2007).
  CAS PubMed PubMed Central Google Scholar
• Hara, E., Tsurui, H., Shinozaki, A., Nakada, S. & Oda, K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179, 528–534 (1991).
  CAS PubMed Google Scholar
• Shay, J. W., Pereira-Smith, O. M. & Wright, W. E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33–39 (1991).
  CAS PubMed Google Scholar
• Counter, C. M. et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921–1929 (1992).
  CAS PubMed PubMed Central Google Scholar
• Shay, J. W., Van Der Haegen, B. A., Ying, Y. & Wright, W. E. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp. Cell Res. 209, 45–52 (1993).
  CAS PubMed Google Scholar
• Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994).
  CAS PubMed Google Scholar
• Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A. & Reddel, R. R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med. 3, 1271–1274 (1997).
  CAS PubMed Google Scholar
• Shay, J. W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787–791 (1997).
  CAS PubMed Google Scholar
• Blasco, M. A., Funk, W., Villeponteau, B. & Greider, C. W. Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267–1270 (1995).
  CAS PubMed Google Scholar
• Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997).
  CAS PubMed Google Scholar
• Herrera, E., Martinez, A. C. & Blasco, M. A. Impaired germinal center reaction in mice with short telomeres. EMBO J. 19, 472–481 (2000).
  CAS PubMed PubMed Central Google Scholar
• Flores, I. et al. The longest telomeres: a general signature of adult stem cell compartments. Genes Dev. 22, 654–667 (2008).
  CAS PubMed PubMed Central Google Scholar
• Rossi, D. J. et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447, 725–729 (2007).
  CAS PubMed Google Scholar
• Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999).
  CAS PubMed Google Scholar
• Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
  CAS PubMed Google Scholar
• Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).
  CAS PubMed Google Scholar
• Greenberg, R. A. et al. Short dysfunctional telomeres impair tumorigenesis in the INK4aΔ2/3 cancer-prone mouse. Cell 97, 515–525 (1999).
  CAS PubMed Google Scholar
• Gonzalez-Suarez, E., Samper, E., Flores, J. M. & Blasco, M. A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nature Genet. 26, 114–117 (2000).
  CAS PubMed Google Scholar
• Rudolph, K. L., Millard, M., Bosenberg, M. W. & DePinho, R. A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nature Genet. 28, 155–159 (2001).
  CAS PubMed Google Scholar
• Dove, W. F. et al. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 353, 915–923 (1998).
  CAS PubMed PubMed Central Google Scholar
• Farazi, P. A. et al. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res. 63, 5021–5027 (2003).
  CAS PubMed Google Scholar
• Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature 436, 642 (2005).
  CAS PubMed Google Scholar
• Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660–665 (2005).
  CAS PubMed Google Scholar
• Collado, M., Blasco, M. A. & Serrano, M. Cellular senescence in cancer and aging. Cell 130, 223–233 (2007).
  CAS PubMed Google Scholar
• Feldser, D. M. & Greider, C. W. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11, 461–469 (2007).
  CAS PubMed PubMed Central Google Scholar
• Cosme-Blanco, W. et al. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep. 8, 497–503 (2007). Using telomerase-knockout mouse models in a setting in which the apoptotic function of p53 is eliminated, references 57 and 58 document for the first time that activation of the cellular senescence programme could potently inhibit tumour initiation and progression in vivo.
  CAS PubMed PubMed Central Google Scholar
• Liu, G. et al. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nature Genet. 36, 63–68 (2004).
  CAS PubMed Google Scholar
• Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661–665 (2007).
  CAS PubMed Google Scholar
• Choudhury, A. R. et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nature Genet. 39, 99–105 (2007).
  CAS PubMed Google Scholar
• Finkel, T., Serrano, M. & Blasco, M. A. The common biology of cancer and ageing. Nature 448, 767–774 (2007).
  CAS PubMed Google Scholar
• Harley, C. B. Telomerase and cancer therapeutics. Nature Rev. Cancer 8, 167–179 (2008).
  CAS Google Scholar
• Shay, J. W. & Keith, W. N. Targeting telomerase for cancer therapeutics. Br. J. Cancer 98, 677–683 (2008).
  CAS PubMed PubMed Central Google Scholar
• Damm, K. et al. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 20, 6958–6968 (2001).
  CAS PubMed PubMed Central Google Scholar
• Dikmen, Z. G. et al. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Cancer Res. 65, 7866–7873 (2005).
  CAS PubMed Google Scholar
• Djojosubroto, M. W. et al. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Hepatology 42, 1127–1136 (2005).
  CAS PubMed Google Scholar
• Hochreiter, A. E. et al. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Clin. Cancer Res. 12, 3184–3192 (2006).
  CAS PubMed Google Scholar
• Jackson, S. R. et al. Antiadhesive effects of GRN163L — an oligonucleotide N3′→P5′ thio-phosphoramidate targeting telomerase. Cancer Res. 67, 1121–1129 (2007).
  CAS PubMed Google Scholar
• Ozawa, T. et al. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts. Neuro Oncol. 6, 218–226 (2004).
  CAS PubMed PubMed Central Google Scholar
• Salvati, E. et al. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J. Clin. Invest. 117, 3236–3247 (2007).
  CAS PubMed PubMed Central Google Scholar
• Campisi, J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513–522 (2005).
  CAS PubMed Google Scholar
• Chin, K. et al. In situ analyses of genome instability in breast cancer. Nature Genet. 36, 984–988 (2004).
  CAS PubMed Google Scholar
• Meeker, A. K. et al. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res. 10, 3317–3326 (2004).
  CAS PubMed Google Scholar
• Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864–870 (2005).
  CAS PubMed Google Scholar
• Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907–913 (2005).
  CAS PubMed Google Scholar
• Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y. & Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA 98, 12072–12077 (2001).
  CAS PubMed PubMed Central Google Scholar
• Baumann, P. & Cech, T. R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292, 1171–1175 (2001).
  CAS PubMed Google Scholar
• He, H. et al. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J. 25, 5180–5190 (2006).
  CAS PubMed PubMed Central Google Scholar
• Loayza, D. & De Lange, T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013–1018 (2003).
  CAS PubMed Google Scholar
• Wu, L. et al. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126, 49–62 (2006).
  CAS PubMed Google Scholar
• Wang, F. et al. The POT1–TPP1 telomere complex is a telomerase processivity factor. Nature 445, 506–510 (2007).
  CAS PubMed Google Scholar
• Xin, H. et al. TPP1 is a homologue of ciliate TEBP-β and interacts with POT1 to recruit telomerase. Nature 445, 559–562 (2007).
  CAS PubMed Google Scholar
• Hockemeyer, D., Daniels, J. P., Takai, H. & de Lange, T. Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 126, 63–77 (2006).
  CAS PubMed Google Scholar
• Hockemeyer, D. et al. Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nature Struct. Mol. Biol. 14, 754–761 (2007).
  CAS Google Scholar
• Celli, G. B. & de Lange, T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nature Cell Biol. 7, 712–718 (2005).
  CAS PubMed Google Scholar
• Chiang, Y. J., Kim, S. H., Tessarollo, L., Campisi, J. & Hodes, R. J. Telomere-associated protein TIN2 is essential for early embryonic development through a telomerase-independent pathway. Mol. Cell Biol. 24, 6631–6634 (2004).
  CAS PubMed PubMed Central Google Scholar
• Munoz, P., Blanco, R. & Blasco, M. A. Role of the TRF2 telomeric protein in cancer and ageing. Cell Cycle 5, 718–721 (2006).
  CAS PubMed Google Scholar
• Kim, W. Y. & Sharpless, N. E. The regulation of INK4/ARF in cancer and aging. Cell 127, 265–275 (2006).
  CAS PubMed Google Scholar
• Jacobs, J. J. & de Lange, T. Significant role for p16INK4A in p53-independent telomere-directed senescence. Curr. Biol. 14, 2302–2308 (2004).
  CAS PubMed Google Scholar
• Herbig, U., Jobling, W. A., Chen, B. P., Chen, D. J. & Sedivy, J. M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but not p16INK4a. Mol. Cell 14, 501–513 (2004).
  CAS PubMed Google Scholar
• Smogorzewska, A. & de Lange, T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21, 4338–4348 (2002).
  CAS PubMed PubMed Central Google Scholar
• Khoo, C. M., Carrasco, D. R., Bosenberg, M. W., Paik, J. H. & Depinho, R. A. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Proc. Natl Acad. Sci. USA 104, 3931–3936 (2007).
  CAS PubMed PubMed Central Google Scholar
• Siegl-Cachedenier, I., Munoz, P., Flores, J. M., Klatt, P. & Blasco, M. A. Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres. Genes Dev. 21, 2234–2247 (2007).
  CAS PubMed PubMed Central Google Scholar
• Qi, L. et al. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Res. 63, 8188–8196 (2003).
  CAS PubMed Google Scholar
• Wong, K. K. et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421, 643–648 (2003).
  CAS PubMed Google Scholar
• Maser, R. S. et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 447, 966–971 (2007).
  CAS PubMed PubMed Central Google Scholar
• Blanco, R., Munoz, P., Flores, J. M., Klatt, P. & Blasco, M. A. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev. 21, 206–220 (2007).
  CAS PubMed PubMed Central Google Scholar